, clinical data of 81 hospitalized patients (male: 48; female: 33; age ranging: 25-65 years) plagued by pleural effusion of uncertain reason and examined by electronic thoracoscope were retrospectively collected and analyzed. Before electronic thoracoscopic examination, all cases were arranged for examinations including pleural routine, biochemistry, exfoliative cytology and pathogenic microbiology yet failed to be diagnosed of pathogenic reason. Accordingly, 500-1000 mL air were injected into thoracic cavity 1 day ahead of electronic thoracoscopic examination.
typical presentation of varied tubercles resembling grape, cauliflower, effusion mass or diffuse incrassation under electronic thoracoscope; 41 cases of tuberculous pleurisy (51.9%) with typical presentation of diffuse pleural hyperaemia, multiple grey miliary nodules, pleural adhesion and pachynsis pleurae under electronic thoracoscope; 6 cases (7.6%) of nonspecific pleural inflammation under electronic thoracoscope; 2 cases of uncertain reason without obvious anomaly under electronic thoracoscope as pleural effusion were completed absorbed during 6-month follow-up. Adverse reactions of electronic thoracoscopic examination were classified as: 10 cases of fever (12.3%), 5 cases of pain of operative lesion (6.1%), which were transient and cured by symptomatic treatment. No severe complication.
Conclusion: Electronic thoracoscopic examination is advantageous
to clinical practice of internal medicine owning to operation convenience, outstanding security and excellent efficiency, thus remarkably conducive to diagnosis of pleural effusion of uncertain reason. using virtual bronchoscopic navigation (VBN) combined with radial endobronchial ultrasound with a guide sheath (TBB with VBN-EBUS-GS) has improved the diagnostic yield of small peripheral lung cancer (PLC). Owing to these procedures, the examination time of TBB for PLC has been shortened in our institution. Further, we have been performing TBB with VBN-EBUS-GS for PLC and EBUS-guided transbronchial needle aspiration (EBUS-TBNA) for lymph node (LN) staging concurrently. However, an evaluation of these procedures performed concurrently has not been reported. We aimed to evaluate the effectiveness and safety of this one-stage combined procedure.
Methods:
We retrospectively assessed 33 cases of lung cancer patients who underwent TBB with VBN-EBUS-GS for PLC and EBUS-TBNA for LN staging concurrently (one-stage procedure) and 31 cases where the procedures were performed on two days (two-stage procedure) from January 2012 to May 2016. The primary endpoints were the diagnostic accuracy of PLC and the total number of LN stations punctured.
Results: There were no significant differences in the median diameter of the major axis of the primary tumour and of the minor axis of the sampled LN between the group of one-and two-stage procedures for patient characteristics. Between the groups, diagnostic accuracy (78.8% vs 87.1%, P = 0.512), and the median number of LN stations punctured (1.0 LN station vs 1.0 LN station, P = 0.218) were not significantly different. Total examination time (41.0 min vs 52.0 min, P<0.001) and the median dose of midazolam per procedure (2.0 mg vs 2.5 mg. P = 0.013) were significantly different between the groups. There were three complications overall.
Conclusion: This study was the first evaluation on the effectiveness and safety of the one-stage combined procedure compared to the twostage procedure in bronchoscopy. The one-stage procedure in bronchoscopy seemed to be equally effective and safer. Results: 1. The aetiology of patients with main tracheal stenosis: tracheal tuberculosis was the main cause of benign tracheal stenosis, followed by tracheotomy and tracheal intubation, and the main cause of malignant tracheal stenosis was squamous cell carcinoma, The second was small cell carcinoma .
2. Multi-joint application of various interventional treatment methods, of which balloon dilatation is mainly used in many times and combined.
3. In patients with benign tracheal stenosis, balloon dilation and basal disease were found to be restenosis (P<0.05) by single factor analysis; single factor analysis found no significant correlation between treatment, primary disease and sex and restenosis in malignant patients (P>0.05). The multivariate logistic regression model showed that in patients with benign tracheal stenosis, the factors of restenosis were balloon dilatation and basal disease (P<0.05).
Conclusion: 1. Tracheal tuberculosis accounts for the first place in the aetiology of benign main tracheal stenosis, followed by tracheal intubation and incision. The aetiology of malignant main tracheal stenosis constitutes the first place of squamous cell carcinoma, followed by small cell lung cancer.
2. For patients with scar stenosis, simple balloon dilatation can relieve symptoms, but the long-term effect is poor. It should be repeated and combined with cryotherapy, stent placement and T-tube placement treatment. 3. Patients with benign main tracheal stenosis who have underlying disease and applied balloon dilatation are prone to tracheal restenosis after interventional treatment. 
